Company: OSRH
Filing Date: 2025-01-31
Form Type: 424B3
Source: 0001213900-25-008874
Chunk: 393

Company: OSR Holdings, Inc.
Filing Date: 2025-01-31
Form: 424B3
Chunk 393
---
 time for which the special meeting is scheduled, the Minimum Available Cash Condition has not been waived by OSR Holdings. As of the date of the filing of the proxy statement/prospectus, BLAC does not expect to meet the Minimum Available Cash Condition and, as a result, OSR Holdings has indicated it will waive this condition to closing of the Business Combination. Consequences if the Adjournment Proposal is Not Approved If the Adjournment Proposal is presented to, but is not approved by BLAC’s stockholders, the BLAC Stockholders’ Meeting will not be adjourned. Vote Required for Approval The Adjournment Proposal requires the vote of a majority of the votes cast by the stockholders present in person or represented by proxy at the BLAC Stockholders’ Meeting and entitled to vote thereon. Abstentions and broker non -voteswill have no impact on the outcome of the Adjournment Proposal. The Adjournment Proposal is not conditioned on the approval of any other proposal set forth in this proxy statement/prospectus. Resolution to be Voted Upon The full text of the resolution to be passed is as follows: “RESOLVED, that the adjournment of the special meeting to a later date or dates to the extent necessary (i) to ensure that any required supplement or amendment to the proxy statement is provided to BLAC stockholders, (ii) to permit the further solicitation and vote of proxies if there are insufficient votes for, or otherwise in connection with, the approval of the Condition Precedent Proposals, or (iii), if as of the time for which the special meeting is scheduled, the Minimum Available Cash Condition has not been waived by OSR Holdings.” Recommendation of the Board of Directors OUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT OUR STOCKHOLDERS VOTE “FOR” THE ADJOURNMENT PROPOSAL. 238 BUSINESS OF OSR HOLDINGS AND CERTAIN INFORMATION ABOUT OSR HOLDINGS Corporate Overview OSR Holdings is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. We aim to build and develop a robust portfolio of innovative and potentially transformative therapies and healthcare solutions. Our current operating businesses (through our three wholly -ownedsubsidiaries) include (i) developing oral immunotherapies for the treatment of cancer, (ii) developing design -augmentedbiologics for age -relatedand other degenerative diseases and (iii) neurovascular intervention medical device and systems